The purchase price for the technology consisted solely of securities of the Company, including Three Million Ten Thousand (3,010,000) shares of the Company's Common Stock and a two-year warrant to purchase an additional One Million (1,000,000) Common shares. The terms of the purchase, including the warrant exercise price, are substantially the same as was provided in the option to purchase the same technology as previously described in our Form 8-K filed with the Securities and Exchange Commission on February 28, 2011.